Skip to main content
Clinical Trials/NCT04872855
NCT04872855
Terminated
Not Applicable

Observational Study to Evaluate the Performance and the Safety of the HLS KneeTec Cementless or Hybrid Fixations in Total Knee Arthroplasty

Corin3 sites in 1 country163 target enrollmentJuly 17, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Total Knee Arthroplasty
Sponsor
Corin
Enrollment
163
Locations
3
Primary Endpoint
Evaluation of implant survival in subjects receiving a total knee arthroplasty with the HLS KneeTec cementless and hybrid fixations up to 10 years after the surgery
Status
Terminated
Last Updated
last year

Overview

Brief Summary

The aim of this study is to assess the long-term performance and safety of HLS KneeTec cementless and hybrid fixation knee prosthesis when used in standard medical practice.

Detailed Description

It is planned to collect prospective and retrospective data from a continuous and exhaustive series of patients in French sites where Total Knee Arthroplasty with HLS Kneetec cementless and hybrid fixation knee prosthesis is performed routinely All patients treated with HLS KneeTec (cementless or hybrid versions) implant will be included. All eligible patients seen in consultation and who agree to participate in the study should be included, systematically and consecutively, since the initiation of the study. Patients will be assessed according to the usual practice of the investigator at each participating site before surgery and then at the follow-up (FU) visits as following: 4 months (+/- 2 months); 1 year (+/- 2 months); 5 years (+/- 12 months) and 10 years (+/- 12 months).

Registry
clinicaltrials.gov
Start Date
July 17, 2020
End Date
December 19, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Corin
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female aged 18 - 80 years old at the time of the surgery
  • Implanted (or with an indication) with an HLS KneeTec Cementless or hybrid fixation according to the Instructions for Use (IFU)
  • Patients agree to consent to collect data from their medical records and agree to answer questionnaires for the purposes of the study.

Exclusion Criteria

  • Patients under guardianship and/or those who, according to the investigator or his delegated research team, will not be able to comply with the study procedures. (e.g. illiteracy, recent psychotic or manic disorders and/or inability to comply with routine follow-up visits.)

Outcomes

Primary Outcomes

Evaluation of implant survival in subjects receiving a total knee arthroplasty with the HLS KneeTec cementless and hybrid fixations up to 10 years after the surgery

Time Frame: 10-year

Kaplan Meier survival rate up to 10 years after the surgery.

Secondary Outcomes

  • Evaluation of safety performance during the surgery up to 10 years after the surgery(starting intraoperatively up to 10-year FU)
  • Radiographic analysis of the HLS KneeTec cementless and hybrid fixations at 4 months, 1, 5 and 10 years minimum(4 months, 1, 5 and 10 years)
  • Evaluation of clinical performance of the HLS KneeTec cementless and hybrid fixations after the surgery(5 and 10 years)

Study Sites (3)

Loading locations...

Similar Trials